Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Agreement
Scancell, PharmaJet sign agreement for melanoma vaccine delivery system
By
LabPulse.com staff writers
Clinical-stage biopharmaceutical company Scancell has signed a strategic partnership agreement with PharmaJet for the supply of PharmaJet's needle-free Stratis delivery system for the delivery of Scancell's advanced melanoma vaccine.
September 18, 2024
CDC adds commercial lab contracts for infectious disease, bird flu testing
By
Liz Carey
Clinical laboratories incentivized to develop diagnostic tests earlier.
September 17, 2024
A. Menarini, Nucleix sign distribution agreement for bladder cancer test
By
LabPulse.com staff writers
A. Menarini Diagnostics and liquid biopsy firm Nucleix have signed a strategic partnership for the exclusive distribution of Nucleix's Bladder EpiCheck test.
September 9, 2024
Carolina Liquid Chemistries, Medline sign distribution deal for POC fentanyl screening test
By
LabPulse.com staff writers
Carolina Liquid Chemistries has forged an agreement with medical supply manufacturer and distributor Medline Industries to distribute its point-of-care fentanyl screening test kit to healthcare providers and clinical laboratories across the U.S.
August 2, 2024
Siga Technologies, HHS sign $113M procurement deal for smallpox, mpox treatment
By
LabPulse.com staff writers
Biotech company Siga Technologies announced that the U.S. Department of Health and Human Services (HHS) exercised a procurement option on an existing contract with Siga to deliver approximately $113 million of the firm's oral antiviral treatment TPoxx.
July 22, 2024
Patient Square Capital to acquire NanoString assets for $220M
By
LabPulse.com staff writers
NanoString Technologies has reached a binding agreement with Patient Square Capital in which NanoString will sell substantially all of its assets to the investment firm for $220 million.
March 11, 2024
Flatiron Health, Guardant Health to integrate tests, EMR platform
By
LabPulse.com staff writers
Flatiron Health and Guardant Health have signed an agreement to integrate Guardant’s genomic profiling test portfolio into Flatiron’s cloud-based OncoEMR electronic medical record (EMR) platform.
November 1, 2023
Astellas snags chance to license Poseida cell therapy in $50M deal
By
Nick Paul Taylor
The agreement gives Astellas first refusal for partnering on P-MUC1C-ALLO1, an allogeneic chimeric antigen receptor (CAR) T cell therapy product candidate that Poseida is developing as a treatment for solid tumors.
August 9, 2023
Guardant and Illumina resolve lawsuit, reach agreement
By
Nick Paul Taylor
In a statement, Guardant said the “three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies.” The request to dismiss includes “any allegations related to the subject intellectual property.”
August 7, 2023
Siemens Healthineers to distribute Scopio Labs’ full-field digital cell morphology technology
By
LabPulse.com staff writers
Siemens Healthineers said the Scopio X100 and Scopio X100HT imaging platforms will complement its IVD systems, including the Atellica Hema 570 and Atellica Hema 580 analyzers.
May 8, 2023
Werfen signs distribution agreement with Thermo Fisher for hemostasis diagnostics system
By
LabPulse.com staff writers
The exclusive, long-term agreement allows Barcelona-based Werfen to continue offering the HemoCell Specialized Lab Automation system.
May 4, 2023
Agilent Technologies, Proscia ink digital pathology distribution agreement
By
LabPulse.com staff writers
Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality, Agilent said.
March 8, 2023
Page 1 of 17
Next Page
